Literature DB >> 11346868

Apoptosis in rectal carcinoma: prognosis and recurrence after preoperative radiotherapy.

G C Adell1, H Zhang, S Evertsson, X F Sun, O H Stål, B A Nordenskjöld.   

Abstract

BACKGROUND: Rectal carcinoma is common, with considerable local recurrence and death rates. Preoperative radiotherapy and refined surgical techniques can improve local control. The aim of this study was to investigate the interaction between apoptosis and the outcome of rectal carcinoma, with and without short-term preoperative radiotherapy.
METHODS: Specimens were from 162 patients from the Southeast Swedish Health Care region included in the Swedish Rectal Cancer Trial between 1987-1990. New sections from the paraffin blocks of the preoperative biopsies and the surgical specimens were examined for apoptosis using the terminal deoxynucleotidyl transferase mediated digoxigenin nick end labeling (TUNEL) method.
RESULTS: The mean percentage of apoptotic cells was 0.3% (0-4%) and 1.1% (0-14.5%) for the preoperative biopsy and the surgical specimen, respectively. The authors analyzed the surgical specimens from nonirradiated patients and divided them into three groups by apoptotic index (AI) as follows: 0%, 0-1%, and > 1%. A high AI was associated with a decreased local recurrence rate compared with an intermediate or a low AI (P = 0.024). There was no significant relation between AI and survival. There was a significant reduction in the local recurrence rate for irradiated patients compared with the nonirradiated in the low (P = 0.015) and intermediate (P = 0.038) AI groups. In the high AI group, there were few recurrences and no significant difference was observed between irradiated and nonirradiated patients. The relative risk of death from rectal carcinoma in Dukes A-C patients was not significantly decreased by radiotherapy, but, in the intermediate AI group, there was a trend (P = 0.08) in favor of the irradiated patients.
CONCLUSION: A high AI in rectal carcinoma indicated a decreased local recurrence rate. Copyright 2001 American Cancer Society.

Entities:  

Mesh:

Year:  2001        PMID: 11346868     DOI: 10.1002/1097-0142(20010515)91:10<1870::aid-cncr1208>3.0.co;2-1

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  14 in total

1.  Survivin expression can predict the effect of chemoradiotherapy for advanced lower rectal cancer.

Authors:  Chie Takasu; Mitsuo Shimada; Nobuhiro Kurita; Takashi Iwata; Hirohiko Sato; Masanori Nishioka; Shinya Morimoto; Kozo Yoshikawa; Tomohiko Miyatani; Hideya Kashihara; Tohru Utsunomiya; Hisanori Uehara
Journal:  Int J Clin Oncol       Date:  2012-08-31       Impact factor: 3.402

2.  Prognostic role of sensitive-to-apoptosis gene expression in rectal cancer.

Authors:  Sevgi A Ozden; Hazan Ozyurt; Zerrin Ozgen; Olca Kilinc; Mustafa Oncel; Aylin E Gul; Nimet Karadayi; Nedime Serakinci; Beki Kan; Oya Orun
Journal:  World J Gastroenterol       Date:  2011-11-28       Impact factor: 5.742

3.  Expression of PIM-1 in salivary gland adenoid cystic carcinoma: Association with tumor progression and patients' prognosis.

Authors:  Xin Zhu; Yunfang Yu; Xiuxiu Hou; Jiajie Xu; Zhuo Tan; Xilin Nie; Zhiqiang Ling; Minghua Ge
Journal:  Oncol Lett       Date:  2017-11-14       Impact factor: 2.967

4.  Preoperative radiochemotherapy is successful also in patients with locally advanced rectal cancer who have intrinsically high apoptotic tumours.

Authors:  M J E M Gosens; R C Dresen; H J T Rutten; G A P Nieuwenhuijzen; J A W M van der Laak; H Martijn; I Tan-Go; I D Nagtegaal; A J C van den Brule; J H J M van Krieken
Journal:  Ann Oncol       Date:  2008-07-29       Impact factor: 32.976

5.  Lack of M30 expression correlates with factors reflecting tumor progression in rectal cancer with preoperative chemoradiotherapy.

Authors:  Susumu Saigusa; Yasuhiro Inoue; Koji Tanaka; Yoshinaga Okugawa; Yuji Toiyama; Keiichi Uchida; Yasuhiko Mohri; Masato Kusunoki
Journal:  Mol Clin Oncol       Date:  2013-09-20

6.  WRAP53 is an independent prognostic factor in rectal cancer- a study of Swedish clinical trial of preoperative radiotherapy in rectal cancer patients.

Authors:  Hong Zhang; Da-Wei Wang; Gunnar Adell; Xiao-Feng Sun
Journal:  BMC Cancer       Date:  2012-07-17       Impact factor: 4.430

7.  PINCH is an independent prognostic factor in rectal cancer patients without preoperative radiotherapy--a study in a Swedish rectal cancer trial of preoperative radiotherapy.

Authors:  Annica Holmqvist; Jingfang Gao; Birgitta Holmlund; Gunnar Adell; John Carstensen; Dianne Langford; Xiao-Feng Sun
Journal:  BMC Cancer       Date:  2012-02-10       Impact factor: 4.430

8.  The prognostic factors and multiple biomarkers in young patients with colorectal cancer.

Authors:  Mo-Jin Wang; Jie Ping; Yuan Li; Gunnar Adell; Gunnar Arbman; Bjorn Nodin; Wen-Jian Meng; Hong Zhang; Yong-Yang Yu; Cun Wang; Lie Yang; Zong-Guang Zhou; Xiao-Feng Sun
Journal:  Sci Rep       Date:  2015-05-27       Impact factor: 4.379

Review 9.  The prognostic value of the apoptosis pathway in colorectal cancer: a review of the literature on biomarkers identified by immunohistochemistry.

Authors:  Eliane C M Zeestraten; Anne Benard; Marlies S Reimers; Philip C Schouten; Gerrit J Liefers; Cornelis J H van de Velde; Peter J K Kuppen
Journal:  Biomark Cancer       Date:  2013-07-04

10.  Gene expression profiling reveals two separate mechanisms regulating apoptosis in rectal carcinomas in vivo.

Authors:  Elza C de Bruin; Simone van de Pas; Cornelis J H van de Velde; J Han J M van Krieken; Lucy T C Peltenburg; Corrie A M Marijnen; Jan Paul Medema
Journal:  Apoptosis       Date:  2007-09       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.